Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiviral”

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT01821963
What this trial is testing

Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC)

Who this might be right for
Infection
M.D. Anderson Cancer Center 1
Not applicableStudy completedNCT03740906
What this trial is testing

Direct-acting Antiviral Therapy and Reinfection Among People With Chronic Hepatitis C Virus Infection and Recent Injecting Drug Use in the Prison Setting

Who this might be right for
Hepatitis C, Chronic
Kirby Institute 202
Testing effectiveness (Phase 2)Study completedNCT01546506
What this trial is testing

Confirmation of the Antiviral Effects of Midodrine Identified With a Gene Expression Signature-based Screening of Inluenza A Virus Infected Cells

Who this might be right for
Influenza A Virus Infection
Hospices Civils de Lyon 79
Not applicableLooking for participantsNCT05466565
What this trial is testing

Antiviral Therapy for Patients With Liver Cancer After Surgery

Who this might be right for
Hepatocellular Carcinoma
Xiangya Hospital of Central South University 360
Large-scale testing (Phase 3)Study completedNCT00784784
What this trial is testing

Zanamivir Versus Trivalent Split Virus Influenza Vaccine

Who this might be right for
Influenza
Mount Sinai Hospital, Canada 64
Not applicableUnknownNCT06373198
What this trial is testing

Implementation of a Re-engagement Program for Hepatitis C Patients Lost to Follow-up in Argentina.

Who this might be right for
Hepatitis C ChronicHepatitis C
Hospital El Cruce 800
Post-approval studies (Phase 4)UnknownNCT03013556
What this trial is testing

Study on an Optimal Antiviral Treatment in HBeAg Positive Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis
Ruijin Hospital 180
Not applicableWithdrawnNCT00001070
What this trial is testing

The Safety and Effectiveness of Different Doses of Vitamin C in HIV-Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Not applicableUnknownNCT03226886
What this trial is testing

TRACERx Renal CAPTURE Sub-study

Who this might be right for
Renal Cell CarcinomaCancerHealthy Volunteers
Royal Marsden NHS Foundation Trust 360
Large-scale testing (Phase 3)Study completedNCT00000841
What this trial is testing

Indinavir Sulfate Plus Zidovudine (AZT) Plus Lamivudine in HIV-Infected Patients Who Have Taken AZT for Six or More Months

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 1,750
Not applicableStudy completedNCT05062408
What this trial is testing

Impact of the Sustained Viral Response of Chronic Hepatitis c After Treatment With Direct Action Antivirals

Who this might be right for
Hepatitis C, Chronic
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 321
Early research (Phase 1)WithdrawnNCT00003435
What this trial is testing

Antiviral Therapy Plus Either Peripheral Stem Cell or Umbilical Cord Blood Transplantation in Treating Patients Who Are HIV Positive and Have Hematologic Cancer

Who this might be right for
LeukemiaLymphoma
Duke University
Testing effectiveness (Phase 2)Study completedNCT04246723
What this trial is testing

Efficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Sofosbuvir in Treatment-naïve Patients With Chronic Hepatitis C Genotype 1

Who this might be right for
Chronic Hepatitis c Genotype 1
R-Pharm 85
Early research (Phase 1)Study completedNCT00000760
What this trial is testing

Study of Activity, Safety, and Tolerance of Oral Ro 24-7429 (Tat Antagonist) in Patients With HIV Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 96
Post-approval studies (Phase 4)Study completedNCT00938860
What this trial is testing

Sustained Virological Response (SVR) to Antiviral Treatment of Liver Transplant Recipients With Recurrent Hepatitis C

Who this might be right for
Hepatitis CLiver Transplantation
Novartis Pharmaceuticals 92
Early research (Phase 1)Looking for participantsNCT05856890
What this trial is testing

HepB mAb19 in Individuals With Chronic Hepatitis B Infection

Who this might be right for
Hepatitis b VirusHepatitis B
Rockefeller University 37
Not applicableEnrolling By InvitationNCT06777173
What this trial is testing

Clinical Study of Antiviral Therapy Combined With Novel Immunotherapy for CHB in Adults

Who this might be right for
Chronic Hepatitis bImmunotherapy
Beijing Ditan Hospital 180
Post-approval studies (Phase 4)Ended earlyNCT03208127
What this trial is testing

DAA Treatment in Donor HCV-positive to Recipient HCV-negative Liver Transplant

Who this might be right for
End Stage Liver DiseaseHepatitis C
Massachusetts General Hospital 33
Post-approval studies (Phase 4)Study completedNCT00001854
What this trial is testing

Long-Term Therapy With Ribavirin for Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 50
Not applicableStudy completedNCT04664894
What this trial is testing

Direct Acting Anti-Viral's In Chronic HCV Patients

Who this might be right for
Safety Issues
Getz Pharma 511
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation